Issue 10/2013
Content (9 Articles)
Leading Article
Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders
Mark J. Niciu, Albert J. Arias
Leading Article
Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression
Kenneth I. Shulman, Nathan Herrmann, Scott E. Walker
Review Article
Neuroprotection in Multiple Sclerosis: A Therapeutic Approach
Amir-Hadi Maghzi, Alireza Minagar, Emmanuelle Waubant
Open Access
Systematic Review
Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
Warrington W. Q. Hsu, C. W. Sing, Ying He, Alan J. Worsley, Ian C. K. Wong, Esther W. Chan
Open Access
Original Research Article
Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder
Tobias Banaschewski, César Soutullo, Michel Lecendreux, Mats Johnson, Alessandro Zuddas, Paul Hodgkins, Ben Adeyi, Liza A. Squires, David Coghill
Original Research Article
Modelling the Risk of Visual Field Loss Arising from Long-Term Exposure to the Antiepileptic Drug Vigabatrin: A Cross-Sectional Approach
John M. Wild, David L. Fone, Saleh Aljarudi, Charlotte Lawthom, Philip E. M. Smith, Robert G. Newcombe, Gareth D. Lewis
Adis Drug Evaluation
Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients
Yahiya Y. Syed, Gillian M. Keating
Letter to the Editor
Comment on: “Management of Alcohol Dependence in Patients With Liver Disease”
Benjamin Rolland, Sylvie Deheul, Alexandre Louvet, Olivier Cottencin, Régis Bordet
Letter to the Editor
Authors’ Reply to Rolland et al.: “Management of Alcohol Dependence in Patients with Liver Disease”
Giovanni Addolorato, Antonio Mirijello